Anxiety and depression in postoperative patients with breast cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Female, aged = 40 years and = 70 years; (2) Postoperative patients and histopathologically diagnosed as breast cancer, according to the Chinese society of clinical oncology breast cancer (CSCOBC) diagnosis and treatment guidelines (2023 version); (3) The score of Hospital anxiety and depression scale (HADS) was =8 and <15; (4) TCM syndrome differentiation as "Liver stagnation" (5) According to the Eastern Cooperative Oncology Group (ECoG) activity status score table, patients with a score of 0 or 1 ("0" stands for completely normal activity ability, without any difference from the activity ability before the onset; "1" stands for free walking and engaging in light physical activities, including general household or office work, but can not engage in heavy physical activities), their survival is predicted to be = 3 months; (6)No history of psychiatric illness in the past, and no psychotropic drugs such as antidepressant and anxiolytic drugs have been taken before entering this study (7) Follow the principle of voluntariness, and sign the informed consent before entering the study.
Exclusion criteria
Exclusion criteria: (1) Patients who are currently receiving surgery or who have surgery plans during the protocol; (2) Patients with severe heart, liver and kidney function injury, respiratory, blood and mental system or combined with other tumor diseases; (3) People who are not suitable for acupuncture treatment, such as: ear trauma, metal implantation higher than the neck level, serious skin disease, allergic constitution; (4)Diagnosis of organic psychiatric disorder and comorbid with other psychiatric disorders, or severe anxiety and depression persistent episodes, who requires psychiatric consultation; (5) Recent encounters with painful life events (e.g., divorce, widowhood, etc.) or traumatic events (e.g., natural disasters, man-made disasters, etc.) (6) Participated in other clinical research topics in the last 3 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hospital anxiety and depression scale, HADS; | — |
Secondary
| Measure | Time frame |
|---|---|
| Hamilton Depression Scale, HAMD;Hamilton Anxiety Scale, HAMA;Pittsburgh Sleep Quality Index (PSQI);Heart rate variability (HRV);Functional Assessment of Cancer Therapy (FACT);Survival follow-up;Dosage taken during the study period; | — |
Countries
China
Contacts
Yueyang Hospital of Integrated Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine